Zdrowie i gospodarka · 18/04/2000

FDA Reopens Comment Period for Human Cellular and Tissue-Based Products Suitability Rule

The FDA is extending the comment period for 90 days for the proposed rule on suitability determinations for donors of human cellular and tissue-based products, following requests from interested parties for more time to review and submit comments.